Bachem Holding AG (LON:0QND)

Market Cap	3.30B
Revenue (ttm)	533.52M
Net Income (ttm)	105.99M
Shares Out	n/a
EPS (ttm)	1.41
PE Ratio	31.18
Forward PE	30.39
Dividend	0.78 (1.49%)
Ex-Dividend Date	May 5, 2025

Volume	2,725
Average Volume	18,456
Open	51.20
Previous Close	51.55
Day's Range	49.40 - 51.20
52-Week Range	43.98 - 91.35
Beta	1.02
RSI	42.75
Earnings Date	Jul 24, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,207
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial numbers in CHF